Corcept Therapeutics Incorporated Free Cash Flow 2000–2025
Corcept Therapeutics Incorporated reported $141.78M of free cash flow for fiscal 2025. That was 27.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -5.9%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $141.78M | -27.7% |
| FY 2024 | $196.12M | +55.0% |
| FY 2023 | $126.54M | +5.5% |
| FY 2022 | $119.91M | -28.4% |
| FY 2021 | $167.42M | +11.1% |
| FY 2020 | $150.73M | +11.6% |
| FY 2019 | $135.03M | +17.0% |
| FY 2018 | $115.37M | +90.6% |
| FY 2017 | $60.52M | +232.6% |
| FY 2016 | $18.20M | +484.5% |
| FY 2015 | $3.11M | +111.3% |
| FY 2014 | $-27.55M | +25.9% |
| FY 2013 | $-37.19M | -2.8% |
| FY 2012 | $-36.17M | -31.9% |
| FY 2011 | $-27.43M | -23.1% |
| FY 2010 | $-22.29M | -24.0% |
| FY 2009 | $-17.97M | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
| FY 2006 | $0 | — |
| FY 2005 | $0 | — |
| FY 2004 | $0 | — |
| FY 2003 | $0 | — |
| FY 2002 | $0 | — |
| FY 2001 | $0 | — |
| FY 2000 | $0 | — |
Source: Corcept Therapeutics Incorporated SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CORT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Corcept Therapeutics Incorporated reported $141.78M of free cash flow for fiscal 2025. That was 27.7% lower than fiscal 2024. Compared with fiscal 2020, the change was -5.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Corcept Therapeutics Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCorcept Therapeutics Incorporated — frequently asked questions
What is Corcept Therapeutics Incorporated's free cash flow?
Corcept Therapeutics Incorporated (CORT) reported free cash flow of $141.78M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Corcept Therapeutics Incorporated's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.